448 related articles for article (PubMed ID: 34725353)
1. Self-inactivating, all-in-one AAV vectors for precision Cas9 genome editing via homology-directed repair in vivo.
Ibraheim R; Tai PWL; Mir A; Javeed N; Wang J; Rodríguez TC; Namkung S; Nelson S; Khokhar ES; Mintzer E; Maitland S; Chen Z; Cao Y; Tsagkaraki E; Wolfe SA; Wang D; Pai AA; Xue W; Gao G; Sontheimer EJ
Nat Commun; 2021 Nov; 12(1):6267. PubMed ID: 34725353
[TBL] [Abstract][Full Text] [Related]
2. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
[TBL] [Abstract][Full Text] [Related]
3. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9-mediated genome editing via postnatal administration of AAV vector cures haemophilia B mice.
Ohmori T; Nagao Y; Mizukami H; Sakata A; Muramatsu SI; Ozawa K; Tominaga SI; Hanazono Y; Nishimura S; Nureki O; Sakata Y
Sci Rep; 2017 Jun; 7(1):4159. PubMed ID: 28646206
[TBL] [Abstract][Full Text] [Related]
5. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
[TBL] [Abstract][Full Text] [Related]
6. Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing.
Bonafont J; Mencía A; Chacón-Solano E; Srifa W; Vaidyanathan S; Romano R; Garcia M; Hervás-Salcedo R; Ugalde L; Duarte B; Porteus MH; Del Rio M; Larcher F; Murillas R
Mol Ther; 2021 Jun; 29(6):2008-2018. PubMed ID: 33609734
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I.
Li N; Gou S; Wang J; Zhang Q; Huang X; Xie J; Li L; Jin Q; Ouyang Z; Chen F; Ge W; Shi H; Liang Y; Zhuang Z; Zhao X; Lian M; Ye Y; Quan L; Wu H; Lai L; Wang K
Mol Ther; 2021 Mar; 29(3):1001-1015. PubMed ID: 33221434
[TBL] [Abstract][Full Text] [Related]
8. Virus-Mediated Genome Editing via Homology-Directed Repair in Mitotic and Postmitotic Cells in Mammalian Brain.
Nishiyama J; Mikuni T; Yasuda R
Neuron; 2017 Nov; 96(4):755-768.e5. PubMed ID: 29056297
[TBL] [Abstract][Full Text] [Related]
9. Efficient viral delivery of Cas9 into human safe harbor.
Hayashi H; Kubo Y; Izumida M; Matsuyama T
Sci Rep; 2020 Dec; 10(1):21474. PubMed ID: 33293588
[TBL] [Abstract][Full Text] [Related]
10. AAV Vectorization of DSB-mediated Gene Editing Technologies.
Moser RJ; Hirsch ML
Curr Gene Ther; 2016; 16(3):207-19. PubMed ID: 27280971
[TBL] [Abstract][Full Text] [Related]
11. ITR-Seq, a next-generation sequencing assay, identifies genome-wide DNA editing sites in vivo following adeno-associated viral vector-mediated genome editing.
Breton C; Clark PM; Wang L; Greig JA; Wilson JM
BMC Genomics; 2020 Mar; 21(1):239. PubMed ID: 32183699
[TBL] [Abstract][Full Text] [Related]
12. Engineering Protein-Secreting Plasma Cells by Homology-Directed Repair in Primary Human B Cells.
Hung KL; Meitlis I; Hale M; Chen CY; Singh S; Jackson SW; Miao CH; Khan IF; Rawlings DJ; James RG
Mol Ther; 2018 Feb; 26(2):456-467. PubMed ID: 29273498
[TBL] [Abstract][Full Text] [Related]
13. Gene editing vectors for studying nicotinic acetylcholine receptors in cholinergic transmission.
Peng C; Yan Y; Kim VJ; Engle SE; Berry JN; McIntosh JM; Neve RL; Drenan RM
Eur J Neurosci; 2019 Aug; 50(3):2224-2238. PubMed ID: 29779223
[TBL] [Abstract][Full Text] [Related]
14. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
Elife; 2021 Dec; 10():. PubMed ID: 34898428
[TBL] [Abstract][Full Text] [Related]
15. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
Bak RO; Porteus MH
Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
[TBL] [Abstract][Full Text] [Related]
16. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
17. Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond.
Valdmanis PN; Kay MA
Hum Gene Ther; 2017 Apr; 28(4):361-372. PubMed ID: 28073291
[TBL] [Abstract][Full Text] [Related]
18. Answered and Unanswered Questions in Early-Stage Viral Vector Transduction Biology and Innate Primary Cell Toxicity for
Dudek AM; Porteus MH
Front Immunol; 2021; 12():660302. PubMed ID: 34122418
[TBL] [Abstract][Full Text] [Related]
19. Transduction and Genome Editing of the Heart with Adeno-Associated Viral Vectors Loaded onto Electrospun Polydioxanone Nonwoven Fabrics.
Furuno K; Suzuki K; Sakai S
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672522
[TBL] [Abstract][Full Text] [Related]
20. CRISPR Systems Suitable for Single AAV Vector Delivery.
Stevanovic M; Piotter E; McClements ME; MacLaren RE
Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]